Showing results (221-230 of 321) with videos related to

Sort By:
Pageof 33
Journal of Cardiac Failure|September 19, 2022
Soluble Urokinase Plasminogen Activator Receptor Levels and Outcomes in Patients with Heart FailureSalim S Hayek, Ayman Samman Tahhan, Yi-An Ko, et al.
Pediatric Nephrology (Berlin, Germany)|May 19, 2025
Ambulatory blood pressure variability in prediction of target organ injury: the SHIP AHOY studyCoral D Hanevold, Jang Dong Seo, Stephen R Daniels, et al.
Stem Cells (Dayton, Ohio)|June 5, 2013
C-kit(+) cells isolated from developing kidneys are a novel population of stem cells with regenerative potentialErika B Rangel, Samirah A Gomes, Raul A Dulce, et al.
The Journal of Pathology|November 20, 2014
BDNF repairs podocyte damage by microRNA-mediated increase of actin polymerizationMin Li, Silvia Armelloni, Cristina Zennaro, et al.
Journal of the American Society of Nephrology : JASN|April 11, 2015
A Podocyte-Based Automated Screening Assay Identifies Protective Small MoleculesHa Won Lee, Samia Q Khan, Mohd Hafeez Faridi, et al.
Hypertension (Dallas, Tex. : 1979)|October 26, 2018
Prediction of Ambulatory Hypertension Based on Clinic Blood Pressure Percentile in AdolescentsGilad Hamdani, Joseph T Flynn, Richard C Becker, et al.
Developmental Cell|June 21, 2017
Apoptosis and Compensatory Proliferation Signaling Are Coupled by CrkI-Containing MicrovesiclesKajal H Gupta, Josef W Goldufsky, Stephen J Wood, et al.
Critical Care Medicine|October 5, 2019
Cell Cycle Biomarkers and Soluble Urokinase-Type Plasminogen Activator Receptor for the Prediction of Sepsis-Induced Acute Kidney Injury Requiring Renal Replacement Therapy: A Prospective, Exploratory StudyChristian Nusshag, Christoph Rupp, Felix Schmitt, et al.
Plos One|September 30, 2010
Podocyte-specific overexpression of wild type or mutant trpc6 in mice is sufficient to cause glomerular diseasePaola Krall, Cesar P Canales, Pamela Kairath, et al.
American Journal of Physiology. Renal Physiology|January 15, 2015
Podocyte injury-driven intracapillary plasminogen activator inhibitor type 1 accelerates podocyte loss via uPAR-mediated β1-integrin endocytosisNamiko Kobayashi, Toshiharu Ueno, Kumi Ohashi, et al.
Pageof 33